SCHEMBL30950214

SCHEMBL30950214

N#Cc1c(Cl)nc2c(Br)cccc2c1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ENPP1 P22413 2/20 0.48
▸ ENPP3 O14638 1/20 0.48
▸ ALDH1A1 P00352 5/20 0.44
▸ KDM4E B2RXH2 3/20 0.37
▸ KMT2A Q03164 6/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ HPGD P15428 3/20 0.37
▸ POLB P06746 1/20 0.37
▸ ALOX12 P18054 1/20 0.37
▸ PRNP P04156 1/20 0.35
▸ DYRK1A Q13627 1/20 0.35
▸ L3MBTL1 Q9Y468 3/20 0.35
▸ TDP1 Q9NUW8 1/20 0.33
▸ GAA P10253 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ GLA P06280 1/20 0.32
▸ LMNA P02545 2/20 0.32
▸ ADORA2A P29274 1/20 0.32
▸ ADORA2B P29275 1/20 0.32
▸ ADORA1 P30542 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28676590 1.00 ENPP1 (0.48) ENPP1ENPP3ALDH1A1KDM4EKMT2A
SCHEMBL31636847 0.84 ENPP3 (0.46) ENPP1ENPP3ALDH1A1KDM4EKMT2A
SCHEMBL24373483 0.81 ALDH1A1 (0.37) ENPP1ALDH1A1KDM4EKMT2AMEN1
SCHEMBL30774158 0.81 ALDH1A1 (0.37) ENPP1ALDH1A1KDM4EKMT2AMEN1
SCHEMBL30774201 0.81 ALDH1A1 (0.50) ALDH1A1KDM4EKMT2AMEN1HPGD
SCHEMBL18264128 0.81 ALDH1A1 (0.50) ALDH1A1KDM4EKMT2AMEN1HPGD
SCHEMBL9794609 0.81 KDM4E (0.39) ALDH1A1KDM4EKMT2AMEN1HPGD
SCHEMBL25805404 0.78 L3MBTL1 (0.34) ENPP1ENPP3ALDH1A1KMT2AMEN1
SCHEMBL24373525 0.77 KDM4E (0.51) ALDH1A1KDM4EKMT2AMEN1HPGD
SCHEMBL29479071 0.77 KDM4E (0.51) ALDH1A1KDM4EKMT2AMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113637005-B KRAS inhibitors for cancer treatment 泰励生物科技(上海)有限公司 2024-05-24 — — CN disclosed
Send feedback